Barclays »

Kezar Life Sciences shares owned by Barclays

Quarter-by-quarter ownership of Kezar Life Sciences (KZR) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Kezar Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Kezar Life Sciences held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kezar Life Sciences by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $4 1 4.00
2025-06-30 $0 1 0.00
2025-03-31 $0 1 0.00
2024-12-31 $0 1 0.00

More positions owned by Barclays

Microsoft Corporation (MSFT)
SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Fund (IWM)
Apple (AAPL)
Tesla Opt Put Option (TSLA)
Amazon Opt Call Option (AMZN)
Alphabet Opt Call Option (GOOGL)
Broadcom Opt Call Option (AVGO)
Facebook Inc cl a (META)
Ishares Tr Opt Call Option (HYG)
JPMorgan Chase & Co. (JPM)
Alphabet Opt Put Option (GOOG)
Berkshire Hathaway Inc Del Opt Put Option (BRK.B)

View all positions for Barclays

Top funds holding Kezar Life Sciences

BML Capital Management
Tang Capital Management
Suvretta Capital Management
Stonepine Capital Management
Vanguard Group
OrbiMed Advisors
Acadian Asset Management
Peapod Lane Capital
ADAR1 Capital Management
Renaissance Technologies
Ikarian Capital
BlackRock
Qiming U.S. Ventures Management
Shay Capital
Geode Capital Management

View all funds holding Kezar Life Sciences